Baxter (BAX) EVP Rosenbloom awarded stock, options as shares withheld for taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Baxter International EVP and General Counsel David S. Rosenbloom reported equity compensation changes and related tax withholding. On February 27, 2026 he received 26,709 shares of common stock and a grant of 64,655 stock options, both at $0.00 per share as awards scheduled to vest in three equal annual installments beginning on March 1, 2027 under Baxter’s 2021 Incentive Plan. On March 2, 2026, 1,336 common shares at $19.69 per share were forfeited to cover taxes from the settlement of previously vested restricted stock units. After these transactions he directly owned 144,837 common shares and 64,655 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Rosenbloom David S.
Role
EVP and General Counsel
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock, $1 par value | 1,336 | $19.69 | $26K |
| Grant/Award | Stock Option (Right to Buy) | 64,655 | $0.00 | -- |
| Grant/Award | Common Stock, $1 par value | 26,709 | $0.00 | -- |
Holdings After Transaction:
Common Stock, $1 par value — 144,837 shares (Direct);
Stock Option (Right to Buy) — 64,655 shares (Direct)
Footnotes (1)
- The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan. Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023. The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.
FAQ
What equity awards did Baxter (BAX) EVP David Rosenbloom receive in this Form 4?
David S. Rosenbloom received a grant of 26,709 shares of Baxter common stock and 64,655 stock options at $0.00 per share. These represent equity compensation awards rather than open-market purchases, tied to Baxter’s 2021 Incentive Plan and vesting conditions.
How and when will David Rosenbloom’s new Baxter (BAX) equity awards vest?
Both the 26,709-share restricted stock unit award and the 64,655 stock options are scheduled to vest in three equal annual installments. Vesting begins on March 1, 2027, which is the first anniversary of the grant date, subject to the applicable plan vesting requirements.
Were David Rosenbloom’s Baxter (BAX) transactions open-market buys or sells?
The reported transactions were not open-market trades. They consisted of equity awards granted at $0.00 per share and a tax-withholding disposition of 1,336 shares at $19.69 per share, used to satisfy taxes on vested restricted stock units, rather than discretionary purchases or sales.
Which Baxter (BAX) incentive plan governs David Rosenbloom’s new awards?
The restricted stock units are subject to vesting requirements in the Amended and Restated Baxter International Inc. 2021 Incentive Plan. This plan sets the conditions under which the 26,709-share award vests, starting March 1, 2027, and continuing in three equal annual installments.